We are excited to invite you to our webinar exploring the innovative integration of Real World Data (RWD) in clinical trials for Amyotrophic Lateral Sclerosis (ALS). As a critical step forward in the pursuit of effective treatments and improved patient outcomes, this webinar aims to shed light on the invaluable insights that RWD can provide.

📅 Date: May 30 | ⏰ Time: 17.00 CEST | 🤝Organized by: TRICALS and Julius Clinical

Hosted by Lieza Exalto, Scientific Officer at Julius Clinical, this webinar will feature Ruben van Eijk, Assistant professor at UMC Utrecht and TRICALS, and Mark van Dijk, Real World Evidence, Early Senior Strategy Lead, UCB Pharma, who will discuss:

  • Hybrid controlled clinical trials using concurrent registries in ALS: A feasibility study
  • Use of real-world data in clinical drug development: An industry perspective

Be prepared to broaden your knowledge, engage in a live Q&A session, and contribute to the evolving dialogue on the integration of RWD in clinical practice. Reserve your spot now via this link: https://app.livestorm.co/julius-clinical/use-of-real-world-data-in-als-clinical-trials?type=detailed